Skip to Content

LU F23 (Minocycline Hydrochloride Extended-Release 135 mg)

Pill with imprint LU F23 is Brown, Capsule-shape and has been identified as Minocycline Hydrochloride Extended-Release 135 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Minocycline is used in the treatment of bacterial infection; acne; bartonellosis; actinomycosis; bullous pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU F23

Minocycline hydrochloride extended-release 135 mg LU F23

Minocycline Hydrochloride Extended-Release

Imprint
LU F23
Strength
135 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
68180-0381

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.